FDA official who scrutinized COVID shots and antidepressants is out in latest shake-up




WASHINGTON (AP) — A Food and Drug Administration official involved in scrutinizing the safety of antidepressants, COVID-19 vaccines and other widely used therapies is stepping down from her role leading the agency’s drug program.



Source link

  • Related Posts

    Riders begin Grey Cup title defence versus Lions – Calgary

    They can’t change history, but Nathan Rourke and the B.C. Lions can exorcise a few demons Saturday night. B.C. opens its season in Regina against the Roughriders. That’s also where…

    IN PHOTOS | Canadian Men’s National Soccer Team training highlights

    Sports Members of Canada’s FIFA World Cup squad take part in a training session at the Toronto FC Training Ground on Wednesday — two days before their tournament opening match…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    B.C. Finance Minister Brenda Bailey diagnosed with ‘early-stage, treatable cancer’

    B.C. Finance Minister Brenda Bailey diagnosed with ‘early-stage, treatable cancer’

    Why British Airways’ Club Suite Door Is Quietly Making A $5,000 First Class Ticket Harder To Justify

    Why British Airways’ Club Suite Door Is Quietly Making A $5,000 First Class Ticket Harder To Justify

    TV Review: ‘IT: Welcome to Derry’

    TV Review: ‘IT: Welcome to Derry’

    Homeland Security Paid $464 Million for Airplanes. Then It Parked Them.

    Homeland Security Paid $464 Million for Airplanes. Then It Parked Them.

    Intergenerational mobility of immigrants in 15 destination countries

    Intergenerational mobility of immigrants in 15 destination countries

    Databricks wanted to raise $1B, investors wanted $15B. It settled on $5B at a $190B valuation.

    Databricks wanted to raise $1B, investors wanted $15B. It settled on $5B at a $190B valuation.